2-bromopyridine;N-hydroxy-4-[[(5-methyl-1,3,4-thiadiazol-2-yl)-pyridin-2-ylamino]methyl]benzamide;methyl 4-[[(5-methyl-1,3,4-thiadiazol-2-yl)-pyridin-2-ylamino]methyl]benzoate;5-methyl-N-pyridin-2-yl-1,3,4-thiadiazol-2-amine;5-methyl-1,3,4-thiadiazol-2-amine;molecular hydrogen

C49H50BrN17O4S4 — CID 158723641

IUPAC2-bromopyridine;N-hydroxy-4-[[(5-methyl-1,3,4-thiadiazol-2-yl)-pyridin-2-ylamino]methyl]benzamide;methyl 4-[[(5-methyl-1,3,4-thiadiazol-2-yl)-pyridin-2-ylamino]methyl]benzoate;5-methyl-N-pyridin-2-yl-1,3,4-thiadiazol-2-amine;5-methyl-1,3,4-thiadiazol-2-amine;molecular hydrogen
SMILESBrc1ccccn1.COC(=O)c1ccc(CN(c2ccccn2)c2nnc(C)s2)cc1.Cc1nnc(N(Cc2ccc(C(=O)NO)cc2)c2ccccn2)s1.Cc1nnc(N)s1.Cc1nnc(Nc2ccccn2)s1.[H][H]
InChIInChI=1S/C17H16N4O2S.C16H15N5O2S.C8H8N4S.C5H4BrN.C3H5N3S.H2/c1-12-19-20-17(24-12)21(15-5-3-4-10-18-15)11-13-6-8-14(9-7-13)16(22)23-2;1-11-18-19-16(24-11)21(14-4-2-3-9-17-14)10-12-5-7-13(8-6-12)15(22)20-23;1-6-11-12-8(13-6)10-7-4-2-3-5-9-7;6-5-3-1-2-4-7-5;1-2-5-6-3(4)7-2;/h3-10H,11H2,1-2H3;2-9,23H,10H2,1H3,(H,20,22);2-5H,1H3,(H,9,10,12);1-4H;1H3,(H2,4,6);1H
InChIKeyIKFLVGTUNIIBJV-UHFFFAOYSA-N
MW1149.23 g/mol
LogP10.57
Rot. Bonds12

About 2-bromopyridine;N-hydroxy-4-[[(5-methyl-1,3,4-thiadiazol-2-yl)-pyridin-2-ylamino]methyl]benzamide;methyl 4-[[(5-methyl-1,3,4-thiadiazol-2-yl)-pyridin-2-ylamino]methyl]benzoate;5-methyl-N-pyridin-2-yl-1,3,4-thiadiazol-2-amine;5-methyl-1,3,4-thiadiazol-2-amine;molecular hydrogen

2-bromopyridine;N-hydroxy-4-[[(5-methyl-1,3,4-thiadiazol-2-yl)-pyridin-2-ylamino]methyl]benzamide;methyl 4-[[(5-methyl-1,3,4-thiadiazol-2-yl)-pyridin-2-ylamino]methyl]benzoate;5-methyl-N-pyridin-2-yl-1,3,4-thiadiazol-2-amine;5-methyl-1,3,4-thiadiazol-2-amine;molecular hydrogen (PubChem CID 158723641) has the molecular formula C49H50BrN17O4S4 and a molecular weight of 1149.23 g/mol. Its IUPAC name is 2-bromopyridine;N-hydroxy-4-[[(5-methyl-1,3,4-thiadiazol-2-yl)-pyridin-2-ylamino]methyl]benzamide;methyl 4-[[(5-methyl-1,3,4-thiadiazol-2-yl)-pyridin-2-ylamino]methyl]benzoate;5-methyl-N-pyridin-2-yl-1,3,4-thiadiazol-2-amine;5-methyl-1,3,4-thiadiazol-2-amine;molecular hydrogen.

Molecular Properties

Compound Name2-bromopyridine;N-hydroxy-4-[[(5-methyl-1,3,4-thiadiazol-2-yl)-pyridin-2-ylamino]methyl]benzamide;methyl 4-[[(5-methyl-1,3,4-thiadiazol-2-yl)-pyridin-2-ylamino]methyl]benzoate;5-methyl-N-pyridin-2-yl-1,3,4-thiadiazol-2-amine;5-methyl-1,3,4-thiadiazol-2-amine;molecular hydrogen
PubChem CID158723641
Molecular FormulaC49H50BrN17O4S4
Molecular Weight1149.23 g/mol
Exact Mass1147.23
IUPAC Name2-bromopyridine;N-hydroxy-4-[[(5-methyl-1,3,4-thiadiazol-2-yl)-pyridin-2-ylamino]methyl]benzamide;methyl 4-[[(5-methyl-1,3,4-thiadiazol-2-yl)-pyridin-2-ylamino]methyl]benzoate;5-methyl-N-pyridin-2-yl-1,3,4-thiadiazol-2-amine;5-methyl-1,3,4-thiadiazol-2-amine;molecular hydrogen
SMILESBrc1ccccn1.COC(=O)c1ccc(CN(c2ccccn2)c2nnc(C)s2)cc1.Cc1nnc(N(Cc2ccc(C(=O)NO)cc2)c2ccccn2)s1.Cc1nnc(N)s1.Cc1nnc(Nc2ccccn2)s1.[H][H]
InChIInChI=1S/C17H16N4O2S.C16H15N5O2S.C8H8N4S.C5H4BrN.C3H5N3S.H2/c1-12-19-20-17(24-12)21(15-5-3-4-10-18-15)11-13-6-8-14(9-7-13)16(22)23-2;1-11-18-19-16(24-11)21(14-4-2-3-9-17-14)10-12-5-7-13(8-6-12)15(22)20-23;1-6-11-12-8(13-6)10-7-4-2-3-5-9-7;6-5-3-1-2-4-7-5;1-2-5-6-3(4)7-2;/h3-10H,11H2,1-2H3;2-9,23H,10H2,1H3,(H,20,22);2-5H,1H3,(H,9,10,12);1-4H;1H3,(H2,4,6);1H
InChIKeyIKFLVGTUNIIBJV-UHFFFAOYSA-N
XLogP10.57
TPSA274.84 Ų
H-Bond Donors4
H-Bond Acceptors24
Rotatable Bonds12
Heavy Atoms75
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5001149.23
LogP ≤ 510.57
H-Bond Donors ≤ 54
H-Bond Acceptors ≤ 1024

Computed Properties (RDKit)

Structural Alerts{'alert_name': '2-halo_pyridine', 'substructure': 'N/A'}, {'alert_name': 'hydroxamic_acid', 'substructure': 'N/A'}, {'alert_name': 'Oxygen-nitrogen_single_bond', 'substructure': 'N/A'}

Analyze 2-bromopyridine;N-hydroxy-4-[[(5-methyl-1,3,4-thiadiazol-2-yl)-pyridin-2-ylamino]methyl]benzamide;methyl 4-[[(5-methyl-1,3,4-thiadiazol-2-yl)-pyridin-2-ylamino]methyl]benzoate;5-methyl-N-pyridin-2-yl-1,3,4-thiadiazol-2-amine;5-methyl-1,3,4-thiadiazol-2-amine;molecular hydrogen with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 2-bromopyridine;N-hydroxy-4-[[(5-methyl-1,3,4-thiadiazol-2-yl)-pyridin-2-ylamino]methyl]benzamide;methyl 4-[[(5-methyl-1,3,4-thiadiazol-2-yl)-pyridin-2-ylamino]methyl]benzoate;5-methyl-N-pyridin-2-yl-1,3,4-thiadiazol-2-amine;5-methyl-1,3,4-thiadiazol-2-amine;molecular hydrogen?
The IUPAC name of 2-bromopyridine;N-hydroxy-4-[[(5-methyl-1,3,4-thiadiazol-2-yl)-pyridin-2-ylamino]methyl]benzamide;methyl 4-[[(5-methyl-1,3,4-thiadiazol-2-yl)-pyridin-2-ylamino]methyl]benzoate;5-methyl-N-pyridin-2-yl-1,3,4-thiadiazol-2-amine;5-methyl-1,3,4-thiadiazol-2-amine;molecular hydrogen (CID 158723641) is 2-bromopyridine;N-hydroxy-4-[[(5-methyl-1,3,4-thiadiazol-2-yl)-pyridin-2-ylamino]methyl]benzamide;methyl 4-[[(5-methyl-1,3,4-thiadiazol-2-yl)-pyridin-2-ylamino]methyl]benzoate;5-methyl-N-pyridin-2-yl-1,3,4-thiadiazol-2-amine;5-methyl-1,3,4-thiadiazol-2-amine;molecular hydrogen.
What is the SMILES notation for 2-bromopyridine;N-hydroxy-4-[[(5-methyl-1,3,4-thiadiazol-2-yl)-pyridin-2-ylamino]methyl]benzamide;methyl 4-[[(5-methyl-1,3,4-thiadiazol-2-yl)-pyridin-2-ylamino]methyl]benzoate;5-methyl-N-pyridin-2-yl-1,3,4-thiadiazol-2-amine;5-methyl-1,3,4-thiadiazol-2-amine;molecular hydrogen?
The canonical SMILES for 2-bromopyridine;N-hydroxy-4-[[(5-methyl-1,3,4-thiadiazol-2-yl)-pyridin-2-ylamino]methyl]benzamide;methyl 4-[[(5-methyl-1,3,4-thiadiazol-2-yl)-pyridin-2-ylamino]methyl]benzoate;5-methyl-N-pyridin-2-yl-1,3,4-thiadiazol-2-amine;5-methyl-1,3,4-thiadiazol-2-amine;molecular hydrogen is Brc1ccccn1.COC(=O)c1ccc(CN(c2ccccn2)c2nnc(C)s2)cc1.Cc1nnc(N(Cc2ccc(C(=O)NO)cc2)c2ccccn2)s1.Cc1nnc(N)s1.Cc1nnc(Nc2ccccn2)s1.[H][H].
What is the InChIKey of 2-bromopyridine;N-hydroxy-4-[[(5-methyl-1,3,4-thiadiazol-2-yl)-pyridin-2-ylamino]methyl]benzamide;methyl 4-[[(5-methyl-1,3,4-thiadiazol-2-yl)-pyridin-2-ylamino]methyl]benzoate;5-methyl-N-pyridin-2-yl-1,3,4-thiadiazol-2-amine;5-methyl-1,3,4-thiadiazol-2-amine;molecular hydrogen?
The InChIKey is IKFLVGTUNIIBJV-UHFFFAOYSA-N. The full InChI is InChI=1S/C17H16N4O2S.C16H15N5O2S.C8H8N4S.C5H4BrN.C3H5N3S.H2/c1-12-19-20-17(24-12)21(15-5-3-4-10-18-15)11-13-6-8-14(9-7-13)16(22)23-2;1-11-18-19-16(24-11)21(14-4-2-3-9-17-14)10-12-5-7-13(8-6-12)15(22)20-23;1-6-11-12-8(13-6)10-7-4-2-3-5-9-7;6-5-3-1-2-4-7-5;1-2-5-6-3(4)7-2;/h3-10H,11H2,1-2H3;2-9,23H,10H2,1H3,(H,20,22);2-5H,1H3,(H,9,10,12);1-4H;1H3,(H2,4,6);1H.
What are the key properties of 2-bromopyridine;N-hydroxy-4-[[(5-methyl-1,3,4-thiadiazol-2-yl)-pyridin-2-ylamino]methyl]benzamide;methyl 4-[[(5-methyl-1,3,4-thiadiazol-2-yl)-pyridin-2-ylamino]methyl]benzoate;5-methyl-N-pyridin-2-yl-1,3,4-thiadiazol-2-amine;5-methyl-1,3,4-thiadiazol-2-amine;molecular hydrogen?
2-bromopyridine;N-hydroxy-4-[[(5-methyl-1,3,4-thiadiazol-2-yl)-pyridin-2-ylamino]methyl]benzamide;methyl 4-[[(5-methyl-1,3,4-thiadiazol-2-yl)-pyridin-2-ylamino]methyl]benzoate;5-methyl-N-pyridin-2-yl-1,3,4-thiadiazol-2-amine;5-methyl-1,3,4-thiadiazol-2-amine;molecular hydrogen has a molecular weight of 1149.23 g/mol, XLogP of 10.57, 12 rotatable bonds, 4 hydrogen bond donors, and 24 hydrogen bond acceptors.
Where does this data come from?
All data for 2-bromopyridine;N-hydroxy-4-[[(5-methyl-1,3,4-thiadiazol-2-yl)-pyridin-2-ylamino]methyl]benzamide;methyl 4-[[(5-methyl-1,3,4-thiadiazol-2-yl)-pyridin-2-ylamino]methyl]benzoate;5-methyl-N-pyridin-2-yl-1,3,4-thiadiazol-2-amine;5-methyl-1,3,4-thiadiazol-2-amine;molecular hydrogen is sourced from PubChem (CID 158723641), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).